I

Inno-Gene SA
WSE:IGN

Watchlist Manager
Inno-Gene SA
WSE:IGN
Watchlist
Price: 5.04 PLN -0.4% Market Closed
Market Cap: 17.7m PLN
Have any thoughts about
Inno-Gene SA?
Write Note

Inno-Gene SA
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Inno-Gene SA
Other Current Liabilities Peer Comparison

Comparables:
M
MDB
R
RVU
S
SLV

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
I
Inno-Gene SA
WSE:IGN
Other Current Liabilities
zł2m
CAGR 3-Years
-38%
CAGR 5-Years
-10%
CAGR 10-Years
-5%
M
Medicofarma Biotech SA
WSE:MDB
Other Current Liabilities
zł836k
CAGR 3-Years
N/A
CAGR 5-Years
53%
CAGR 10-Years
N/A
R
Ryvu Therapeutics SA
WSE:RVU
Other Current Liabilities
zł30.1m
CAGR 3-Years
68%
CAGR 5-Years
N/A
CAGR 10-Years
16%
S
Selvita SA
WSE:SLV
Other Current Liabilities
zł7.5m
CAGR 3-Years
54%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Inno-Gene SA's Other Current Liabilities?
Other Current Liabilities
2m PLN

Based on the financial report for Jun 30, 2024, Inno-Gene SA's Other Current Liabilities amounts to 2m PLN.

What is Inno-Gene SA's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
-5%

Over the last year, the Other Current Liabilities growth was 140%. The average annual Other Current Liabilities growth rates for Inno-Gene SA have been -38% over the past three years , -10% over the past five years , and -5% over the past ten years .

Back to Top